10th Jan 2008 17:34
Skyepharma PLC10 January 2008 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES (1). Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached: SKYEPHARMA PLC 2. Reason for the notification (please state Yes/No): ( ) An acquisition or disposal of voting rights: ( X ) An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : ( ) 3. Full name of person(s) subject to the notification obligation: The Goldman Sachs Group, Inc. 4. Full name of shareholder(s) (if different from 3.): Goldman, Sachs & Co.Goldman Sachs International 5. Date of the transaction and date on which the threshold is crossed or reachedif different): 08 January 2008 6. Date on which issuer notified: 10 January 2008 7. Threshold(s) that is/are crossed or reached: 6% 8. Notified details: A: Voting rights attached to shares Class/type of shares Situation previous to if possible using the the Triggering ISIN CODE transaction Number of shares Number of voting Rights GB0008123571 41,229,156 5.059% US8308081012 7,730 0.001% Resulting situation after the triggering transaction Class/type of shares Number of shares Number of voting rights % of voting rights if possible using the ISIN CODE Direct Direct Indirect Direct Indirect GB0008123571 504,322 49,168,934 0.062% 6.033% US8308081012 2,730 0.000% B: Financial Instruments Resulting situation after the triggering transaction Type of Expiration Date Exercise/Conversion Number of voting % of voting financial Period/ Date rights that may be rights instrument acquired if the instrument is exercised/ converted. Total (A+B)Number of voting rights % of voting rights 49,675,986 6.10% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: The interest in 45,922 shares arose from a beneficial interest held byGoldman, Sachs & Co. ("GS&Co."), a direct subsidiary of GS Inc. These sharesare, or will be, registered in the name of Goldman Sachs Securities (Nominees),Limited ("GSSN"). The interest in 49,168,934 shares arose from an interest held by Goldman, Sachs& Co., a wholly-owned direct subsidiary of GS Inc. acting as custodian for its customers. These shares are, or will be, registered in the name of GoldmanSachs Securities (Nominees), Limited. The interest in 458,400 shares arose from a beneficial interest held byGoldman Sachs International, a wholly-owned indirect subsidiary of GS Inc. These shares are, or will be, registered at CREST in account CREPTEMP. The interest in 2,730 shares arose from an interest held by Goldman, Sachs &Co., a wholly-owned direct subsidiary of GS Inc, acting as custodian for itscustomers of 273 American Depositary Receipts ("ARDs"). These ARDs are, or willbe, held at the Depositary Trust Company of New York ("DTC"). Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: General email contact: [email protected] 14: Contact name: Sean Rogers / Alan Cox 15. Contact telephone number: 0207-552-9205 / 0207-774-8774 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L